We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Host Genetic, Environmental Factors Influence Urinary Tract Microbiome

By LabMedica International staff writers
Posted on 14 Aug 2020
Print article
Graphic representation of how the urinary tract microbiome in older women exhibits host genetic and environmental influences (Photo courtesy of King\'s College London).
Graphic representation of how the urinary tract microbiome in older women exhibits host genetic and environmental influences (Photo courtesy of King\'s College London).
The urinary microbiome is a relatively unexplored niche that varies with gender. Urinary microbes, especially in aging populations, are associated with morbidity. Both genetic and environmental factors influence the makeup of the urinary tract microbiome of older women.

The term “urine microbiome” is being proposed as a term denouncing the old paradigm, that urine in the bladder is usually sterile. The bacterial species include lactobacilli, obligate anaerobes, Gardnerella vaginalis, non-hemolytic streptococci, Mycoplasma and Ureaplasma amongst others.

Medical Scientists from King's College London (London, UK) carried out a large-scale study exploring factors defining urinary microbiome composition in community-dwelling older adult women without clinically active infection. Using 1,600 twins, they estimated the contribution of genetic and environmental factors to microbiome variation.

The investigators performed 16S rRNA sequencing of midstream urine samples from the mostly post-menopausal women from the TwinsUK cohort. When they compared the composition of these samples to the previously published microbiomes of other body sites, they found the diversity of the urine dataset to be similar to that of the vaginal dataset, but that it was not as diverse as the stool dataset. Within the urinary tract microbiome, they identified a set of 61 core microbial taxa. As compared to the gut microbiome dataset, the urinary tract microbiome included more Actinobacteria, Fusobacteria, and Proteobacteria, but fewer Bacteroidetes, Firmicutes, and Verrumicrobia. For a subset of participants, they also generated shotgun metagenomic data in addition to the 16S data. The core microbiome they identified through the 16S data was largely recapitulated in the metagenomic dataset.

By using three different measurements, heritability, family segregation, and ancestry-based analyses, they found a significant effect of host genetics on the composition of the urine microbiome. In particular, for the core microbiome, they found that nearly a quarter of those variants that were found in at least 5% of participants had heritability estimates larger than 10%. One of these, Escherichia-Shigella, has been implicated in urinary tract infections and suggests host genetics may contribute to such infections.

The authors concluded that the urinary microbiome was distinct and apparently unrelated to stool microbiome. It shows a significant contribution of host genetics. Key species known to be clinically relevant were among the most heritable microbes. The study was published on July 21, 2020 in the journal Cell Host & Microbe.

Related Links:

King's College London

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Multi-Function Pipetting Platform
apricot PP5
New
Auto Clinical Chemistry Analyzer
cobas c 703

Print article

Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more
Sekisui Diagnostics UK Ltd.